Theratechnologies Inc.
2310 Alfred-Nobel Boulevard
Saint-Laurent
Quebec
H4S 2A4
Canada
Tel: 514-336-7800
Fax: 514-336-7242
Website: http://www.theratech.com/
Email: webinfo@theratech.com.
326 articles about Theratechnologies Inc.
-
Theratechnologies Says 82.5% of Patients Achieved Primary Endpoint in Phase III Ibalizumab Trial
5/24/2016
-
Theratechnologies, TaiMed Biologics Forge $120.5 Million Ibalizumab Pact
3/18/2016
-
Theratechnologies Inc. To Announce Financial Results For Fiscal Year 2015
2/11/2016
-
Health Canada Approves EGRIFTA (Tesamorelin For Injection) And Theratechnologies Inc. Regains Canadian Commercialization Rights To EGRIFTA
4/30/2014
-
Theratechnologies Inc. To Announce Financial Results For Fiscal Year 2013
2/26/2014
-
Theratechnologies Inc. Suspends Most Long-Term R&D Activities, Cuts Jobs
10/30/2012
-
Theratechnologies Inc. CEO Exits Role as Company Tightens Third-Quarter Loss
10/12/2012
-
Theratechnologies Inc. Cuts 60% of Workforce, Refocus for 2013
12/7/2011
-
Theratechnologies Inc. President and CEO to Ring The NASDAQ Stock Market Opening Bell
6/15/2011
-
Theratechnologies Inc. Adopts New R&D Business Model to Strengthen Its Growth Potential; Cuts 24 Jobs
6/2/2011
-
Theratechnologies Inc. Announces a Distribution and Licensing Agreement for EGRIFTA(TM) in Latin America, Africa and the Middle East With Sanofi-Aventis (France)
12/6/2010
-
Notice of Conference Call & Media Advisory: Theratechnologies Inc. Announces a Partnership Agreement
12/6/2010
-
Theratechnologies Inc. Plans Early Adoption of International Financial Reporting Standards
12/2/2010
-
Theratechnologies Inc. Welcomes the Arrival of Its New President and CEO
12/1/2010
-
FDA Approves Theratechnologies Inc.'s EGRIFTA(TM) (Tesamorelin for Injection): First and Only Treatment for the Reduction of Excess Abdominal Fat in HIV-infected Patients with Lipodystrophy
11/11/2010
-
Theratechnologies Inc. Announces the Retirement Date for the President and CEO: Mr. Yves Rosconi
10/14/2010
-
Theratechnologies Inc. Announces Results for the Third Quarter 2010: Lower Burn Rate and Solid Financial Position
10/13/2010
-
Theratechnologies Inc. to Present at BioContact Quebec
10/5/2010
-
Theratechnologies Inc. to Present at UBS Global Life Sciences Conference
9/20/2010
-
Theratechnologies Inc.: Tesamorelin Data Presented at the Interscience Conference on Antimicrobial Agents and Chemotherapy 50th Annual Meeting
9/13/2010